Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Sandoz PolskaSandoz Polska
VS
Dr. Reddy's LaboratoriesDr. Reddy's Laboratories
Sandoz Polska

Sandoz Polska

ulica Domaniewska, Warszawa, 02-622, PL

Last Update: 01/03/2026

View Profile
Between 750 and 799
https://sandoz.pl/
755/1000Fair

Sandoz Polska jest spółką stowarzyszoną Sandoz Global, tj. światowego lidera w dziedzinie leków generycznych i biologicznych biorównoważnych. Celem naszego działania jest wprowadzanie pionierskich rozwiązań zapewniających pacjentom na całym świecie dostęp do leków. Prze...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:434
Subsidiaries:24
12-month incidents
0
Known data breaches
0
Attack type number
0
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TS, IN, 500034

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.drreddys.com
783/1000Fair

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including AP...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:31,653
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Sandoz Polska

Sandoz Polska

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Polska in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Dr. Reddy's Laboratories in 2026.

Incidents

Incident History - Sandoz Polska (X = Date, Y = Severity)

Sandoz Polska cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Dr. Reddy's Laboratories (X = Date, Y = Severity)

Dr. Reddy's Laboratories cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Sandoz Polska

Sandoz Polska

Incidents
No explicit notable incidents reported.
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Incidents
No explicit notable incidents reported.

FAQ

Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has the best AI Cybersecurity Score ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has experienced more cyber incidents in the past ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has experienced more cyber incidents this year ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has experienced at least one ransomware attack ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has experienced at least one data breach ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has experienced at least one targeted cyberattack ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has experienced at least one vulnerability ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one holds the most compliance certifications ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one holds the fewest compliance certifications ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has the most subsidiaries ?
Between Sandoz Polska company and Dr. Reddy's Laboratories company, which one has the largest number of employees ?
Between Sandoz Polska and Dr. Reddy's Laboratories, which company holds both SOC 2 Type 1 certifications ?
Between Sandoz Polska and Dr. Reddy's Laboratories, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Sandoz Polska or Dr. Reddy's Laboratories ?
Which company is PCI DSS compliant - Sandoz Polska or Dr. Reddy's Laboratories ?
Between Sandoz Polska and Dr. Reddy's Laboratories, which company complies with HIPAA regulations for healthcare data ?
Between Sandoz Polska and Dr. Reddy's Laboratories, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
REFERENCES